ArticleCell death discovery2022

Sorafenib inhibits LPS-induced inflammation by regulating Lyn-MAPK-NF-kB/AP-1 pathway and TLR4 expression.

Xiaolian Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.